Salomon & Ludwin, LLC Astrazeneca PLC Transaction History
Salomon & Ludwin, LLC
- $1.1 Billion
- Q3 2025
A detailed history of Salomon & Ludwin, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Salomon & Ludwin, LLC holds 766 shares of AZN stock, worth $68,480. This represents 0.01% of its overall portfolio holdings.
Number of Shares
766
Previous 72
963.89%
Holding current value
$68,480
Previous $5,000
1060.0%
% of portfolio
0.01%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,498Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...